Header Logo

Connection

EDWARD GRAVISS to Antitubercular Agents

Back to Details
This is a "connection" page, showing publications EDWARD GRAVISS has written about Antitubercular Agents.
EDWARD GRAVISS
Connection Strength
3.754
Antitubercular Agents
  1. Texas tuberculosis research symposium 2018: Research and clinical collaboration within the State of Texas - Moving towards elimination of TB. Tuberculosis (Edinb). 2019 05; 116S:S1.
    View in: PubMed
    Score: 0.562
  2. Development and validation of a risk score to predict mortality during TB treatment in patients with TB-diabetes comorbidity. BMC Infect Dis. 2019 Jan 05; 19(1):10.
    View in: PubMed
    Score: 0.548
  3. Can mycobacterial katG genetic changes in isoniazid-resistant tuberculosis influence human disease features? Int J Tuberc Lung Dis. 2013 May; 17(5):644-51.
    View in: PubMed
    Score: 0.365
  4. Incidence of moxifloxacin resistance in clinical Mycobacterium tuberculosis isolates in Houston, Texas. J Clin Microbiol. 2011 Aug; 49(8):2942-5.
    View in: PubMed
    Score: 0.324
  5. High-level rifampin resistance correlates with multiple mutations in the rpoB gene of pulmonary tuberculosis isolates from the Afghanistan border of Iran. J Clin Microbiol. 2009 Sep; 47(9):2744-50.
    View in: PubMed
    Score: 0.287
  6. Drug-resistant tuberculosis: a disease of target populations in Houston, Texas. J Infect. 2006 Jul; 53(1):5-11.
    View in: PubMed
    Score: 0.221
  7. Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. J Med Microbiol. 2004 Feb; 53(Pt 2):107-113.
    View in: PubMed
    Score: 0.195
  8. Prognostic score to predict mortality during TB treatment in TB/HIV co-infected patients. PLoS One. 2018; 13(4):e0196022.
    View in: PubMed
    Score: 0.130
  9. Clinical and bacteriological characteristics associated with clustering of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2017 07 01; 21(7):766-773.
    View in: PubMed
    Score: 0.122
  10. Predictive value of serum bradykinin and desArg9-bradykinin levels for chemotherapeutic responses in active tuberculosis patients: A retrospective case series. Tuberculosis (Edinb). 2016 12; 101S:S109-S118.
    View in: PubMed
    Score: 0.117
  11. Characterization of 2-hydroxy-1-naphthaldehyde isonicotinoyl hydrazone as a novel inhibitor of methionine aminopeptidases from Mycobacterium tuberculosis. Tuberculosis (Edinb). 2016 12; 101S:S73-S77.
    View in: PubMed
    Score: 0.117
  12. Mycobacterium tuberculosis bacteraemia: experience from a non-endemic urban centre. Clin Microbiol Infect. 2014 Mar; 20(3):263-8.
    View in: PubMed
    Score: 0.094
  13. Transmission of multidrug-resistant tuberculosis in the USA: a cross-sectional study. Lancet Infect Dis. 2013 Sep; 13(9):777-84.
    View in: PubMed
    Score: 0.093
  14. Population-based surveillance of extensively drug-resistant tuberculosis in Shandong Province, China. Int J Tuberc Lung Dis. 2012 May; 16(5):612-4.
    View in: PubMed
    Score: 0.085
  15. Laboratory-based surveillance of extensively drug-resistant tuberculosis, China. Emerg Infect Dis. 2011 Mar; 17(3):495-7.
    View in: PubMed
    Score: 0.080
  16. Detection by denaturing gradient gel electrophoresis of pncA mutations associated with pyrazinamide resistance in Mycobacterium tuberculosis isolates from the United States-Mexico border region. Antimicrob Agents Chemother. 2005 Jun; 49(6):2210-7.
    View in: PubMed
    Score: 0.053
  17. Genetic polymorphism in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosis. J Infect Dis. 2004 Jul 01; 190(1):99-106.
    View in: PubMed
    Score: 0.050
  18. Anti-Tuberculosis Potential of OJT008 against Active and Multi-Drug-Resistant Mycobacterium Tuberculosis: In Silico and In Vitro Inhibition of Methionine Aminopeptidase. Int J Mol Sci. 2023 Dec 05; 24(24).
    View in: PubMed
    Score: 0.048
  19. Treatment of isoniazid-resistant tuberculosis in southeastern Texas. Chest. 2001 Jun; 119(6):1730-6.
    View in: PubMed
    Score: 0.040
  20. Tuberculosis endotypes to guide stratified host-directed therapy. Med. 2021 03 12; 2(3):217-232.
    View in: PubMed
    Score: 0.039
  21. Head and neck tuberculosis: Literature review and meta-analysis. Tuberculosis (Edinb). 2019 05; 116S:S78-S88.
    View in: PubMed
    Score: 0.035
  22. Risk factors for extrapulmonary dissemination of tuberculosis and associated mortality during treatment for extrapulmonary tuberculosis. Emerg Microbes Infect. 2018 Jun 06; 7(1):102.
    View in: PubMed
    Score: 0.033
  23. School-based Study to Identify and Treat Adolescent Students at Risk for Tuberculosis Infection. Pediatr Infect Dis J. 2016 07; 35(7):733-8.
    View in: PubMed
    Score: 0.029
  24. Characteristics and costs of multidrug-resistant tuberculosis in-patient care in the United States, 2005-2007. Int J Tuberc Lung Dis. 2016 Apr; 20(4):435-41.
    View in: PubMed
    Score: 0.028
  25. Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005-2007. Emerg Infect Dis. 2014 May; 20(5):812-21.
    View in: PubMed
    Score: 0.025
  26. Intracranial tuberculomas in adults: a report of twelve consecutive patients in Houston, Texas. Scand J Infect Dis. 2011 Oct; 43(10):785-91.
    View in: PubMed
    Score: 0.020
  27. A report of cutaneous tuberculosis in siblings. Pediatr Dermatol. 2003 Sep-Oct; 20(5):404-7.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.